Vastavam web: The government has directed coronary stent makers to maintain the production and supply of stents in the country amid reports of shortage in market and hospitals, according to an official order. The government has invoked powers of section 3 (i) of the Drug Prices Control Order, 2013 to ensure adequate availability of stents, according to a notification by the Department of Pharmaceuticals (DoP). The notification has come after the National Pharmaceuticals Pricing Authority (NPPA), earlier this week, allowed Abbott Healthcare to withdraw its latest drug eluting stent Xience Alpine from the Indian market. The NPPA had said that as the Department of Pharmaceuticals had not accepted its request to invoke powers under para 3 of DPCO 2013, it was left with no option but allow formal withdrawal of the stent. “Some reports regarding shortage of coronary stents in the market/hospitals have now come to the notice of the department” the DoP notification said.